Correlation between serum matrix metalloproteinase-2/tissue inhibitors of metalloproteinase-2 ratio and elevated pulmonary vascular resistance

被引：0
|
作者：
Hisazaki, K. [1 ]
Uzui, H. [1 ]
Arakawa, K. [1 ]
Amaya, N. [1 ]
Kaseno, K. [1 ]
Ishida, K. [1 ]
Morishita, T. [1 ]
Sato, T. [1 ]
Lee, J. D. [1 ]
Tada, H. [1 ]
机构：
[1] Univ Fukui, Fukui 910, Japan
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] Immunohistochemical Correlation of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Tobacco Associated Epithelial Dysplasia
    Bajracharya, Dipshikha
    Shrestha, Bijayatha
    Kamath, Asha
    Menon, Aparna
    Radhakrishnan, Raghu
    [J]. DISEASE MARKERS, 2014, 2014
  • [2] IMPACT OF SERUM MATRIX METALLOPROTEINASE-2 LEVELS ON PULMONARY VASCULAR RESISTANCE ELEVATION
    Hisazaki, Kaori
    Morishita, Tetsuji
    Uzui, Hiroyasu
    Arakawa, Kenichiro
    Amaya, Naoki
    Ishida, Kentaro
    Sato, Takehiko
    Fukuoka, Yoshitomo
    Ikeda, Hiroyuki
    Maeda, Chiyo
    Koike, Machiko
    Sato, Yusuke
    Yamaguchi, Junya
    Lee, Jong-Dae
    Tada, Hiroshi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1293 - E1293
  • [3] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [4] Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients
    Drzewiecka-Jedrzejczyk, Magdalena
    Wlazel, Rafal
    Terlecka, Monika
    Jablonski, Slawomir
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 5306 - 5313
  • [5] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231
  • [6] Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma
    Xu, KX
    Hou, SK
    Du, ZJ
    [J]. CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 743 - 745
  • [7] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
    Li, Bing-Hui
    Zhao, Peng
    Liu, Shi-Zheng
    Yu, Yue-Ming
    Han, Mei
    Wen, Jin-Kun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) : 3046 - 3050
  • [8] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 gene polymorphisms in multiple sclerosis
    Benesova, Y.
    Beranek, M.
    Hladikova, M.
    Vacha, J.
    Kadanka, Z.
    Vasku, A.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 68 - 68
  • [9] An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy
    Han, Sang Youb
    Jee, Yi Hwa
    Han, Kum Hyun
    Kang, Young Sun
    Kim, Hyoung Kyu
    Han, Jee Young
    Kim, Young Sik
    Cha, Dae Ryong
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2406 - 2416
  • [10] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
12345